The 37 ranking InvestorsObserver offers to ProPhase Labs Inc (PRPH) stock puts it close to the leading of the Drug Suppliers – Specialty & Generic market. In addition to scoring larger than 74 percent of stocks in the Drug Suppliers – Specialty & Generic market, PRPH’s 37 general score suggests the inventory scores far better than 37 % of all shares.
What do These Rankings Necessarily mean?
Seeking for the most effective shares to invest in can be tough. There are 1000’s of possibilities and it can be confusing on what really constitutes a terrific benefit. Traders Observer makes it possible for you to decide on from eight exclusive metrics to watch the prime industries and the very best carrying out shares in that field. A rating of 37 would rank higher than 37 p.c of all stocks.
Our proprietary scoring procedure captures technical things, elementary examination and the opinions of analysts on Wall Street. This can make InvestorsObserver’s overall score a terrific way to get begun, no matter of your investing design and style. Percentile-ranked scores are also simple to have an understanding of. A rating of 100 is the top rated and a is the base. There’s no need to try to keep in mind what is “good” for a bunch of challenging ratios, just spend awareness to which numbers are the greatest.
What’s Taking place With ProPhase Labs Inc Inventory Today?
ProPhase Labs Inc (PRPH) stock has fallen -8.35% although the S&P 500 is up 1.48% as of 2:15 PM on Monday, Apr 5. PRPH is lessen by -$.57 from the previous closing selling price of $6.83 on volume of 229,951 shares. About the past calendar year the S&P 500 is up 53.14% even though PRPH is up 229.47%. PRPH dropped -$.14 per share the more than the previous 12 months.
Click on Below to get the full Stock Score Report on ProPhase Labs Inc (PRPH) Inventory.